Jump Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Jump Financial's VRTX Position: Q2 2026 in Review
Jump Financial increased its Vertex Pharmaceuticals (VRTX) stake by 29% in Q2 2026, buying an estimated $116K and bringing the position to 1,161 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #1408.
Jump Financial first reported a position in VRTX in Q3 2020 and has held it in 18 quarters since. The position peaked at $12.5M in Q4 2023. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Jump Financial held 1,161 shares of Vertex Pharmaceuticals worth $577K as of Q2 2026.
- Jump Financial bought 262 Vertex Pharmaceuticals shares in Q2 2026, an estimated $116K.
- Vertex Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1408 holding.
- Jump Financial first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
- Jump Financial's Vertex Pharmaceuticals position peaked at $12.5M in Q4 2023.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.